TABLE 2.

Associations between serum FABP4 and FLI.

Group	All			Diabetes			Obesity			Metabolic syndrome
	β	P	R 2	β	P	R 2	β	P	R 2	β	P	R 2
Crude	0.276	<0.001	0.076	0.267	<0.001	0.071	0.259	<0.001	0.067	0.193	0.001	0.037
Model 1	0.323	<0.001	0.127	0.267	<0.001	0.165	0.303	<0.001	0.149	0.259	<0.001	0.170
Model 2	0.255	<0.001	0.424	0.251	<0.001	0.306	0.308	<0.001	0.290	0.256	<0.001	0.286

Univariate (Crude model) and multivariate stepwise linear regression analysis showing associations between serum FABP4 and FLI in the whole population (All), diabetes, obesity and metabolic syndrome patients. FLI was entered as a dependent variable and FABP4, age, gender (Model 1) and FABP4, age, gender, glucose, triglycerides, apoA1, apoB100 and AST (Model 2) were subsequently entered as independent variables. Data are expressed as standardized beta (β) and P-values and R² are shown.